CN Stock MarketDetailed Quotes

301033 Medprin Regenerative Medical Technologies

Watchlist
  • 44.13
  • +0.46+1.05%
Post Market Oct 17 15:00 CST
2.92BMarket Cap47.50P/E (TTM)

Medprin Regenerative Medical Technologies Key Stats

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
42.39%122.05M
28.59%57.21M
18.24%230.87M
4.69%145.78M
-9.80%85.72M
19.35%44.49M
26.96%195.25M
34.75%139.25M
38.24%95.02M
14.63%37.27M
Operating revenue
42.39%122.05M
28.59%57.21M
18.24%230.87M
4.69%145.78M
-9.80%85.72M
19.35%44.49M
26.96%195.25M
34.75%139.25M
38.24%95.02M
14.63%37.27M
Other operating revenue
131.88%2.88M
----
1,308.63%3.33M
----
--1.24M
----
--236.57K
----
--0
----
Total operating cost
22.30%91.46M
15.86%43.04M
11.95%189.59M
4.31%119.87M
-4.58%74.79M
15.16%37.15M
33.03%169.36M
47.35%114.92M
57.11%78.37M
37.69%32.25M
Operating cost
49.26%25.81M
23.73%10.7M
33.03%41.54M
34.92%27.67M
24.75%17.29M
44.03%8.65M
15.28%31.23M
9.75%20.51M
8.14%13.86M
-4.86%6.01M
Operating tax surcharges
14.79%2.27M
19.42%1.16M
123.75%4.57M
145.54%3.05M
220.05%1.98M
1,237.64%967.22K
211.09%2.04M
119.97%1.24M
69.31%617.91K
-52.42%72.31K
Operating expense
-3.32%22.77M
1.91%12.23M
-12.13%61.75M
-22.37%38.39M
-33.38%23.55M
-8.23%12.01M
44.61%70.27M
69.24%49.45M
86.65%35.35M
55.58%13.08M
Administration expense
49.29%29.71M
43.57%13.51M
54.18%54.42M
42.36%32.95M
32.04%19.9M
29.47%9.41M
44.61%35.3M
54.47%23.15M
62.46%15.07M
54.63%7.27M
Financial expense
-398.55%-144.51K
-65.10%158.09K
630.85%531.59K
142.81%253.17K
191.19%48.41K
117.78%453.01K
-114.67%-100.14K
-226.76%-591.31K
-111.37%-53.08K
-22.93%208.01K
-Interest expense (Financial expense)
-22.92%866.9K
-11.70%508.27K
23.80%2.21M
157.60%1.67M
441.83%1.12M
436.00%575.62K
260.58%1.78M
54.35%649.97K
-19.14%207.57K
-15.60%107.39K
-Interest Income (Financial expense)
-2.58%-976.78K
5.21%-469.69K
-90.35%-1.88M
-177.23%-1.41M
-610.99%-952.21K
-838.50%-495.53K
-151.02%-989.7K
-90.69%-509.01K
-54.86%-133.93K
-47.45%-52.8K
Research and development
-8.05%11.05M
-6.77%5.28M
-12.53%26.78M
-17.03%17.56M
-11.16%12.02M
0.74%5.66M
18.31%30.61M
50.41%21.16M
68.64%13.53M
56.80%5.62M
Credit Impairment Loss
52.14%-10.94K
77.60%-9.26K
-330.09%-36.56K
-210.77%-51.1K
52.28%-22.87K
-210.69%-41.35K
-132.18%-8.5K
-129.49%-16.44K
-190.48%-47.91K
-237.27%-13.31K
Asset Impairment Loss
98.67%-212.18
116.18%1.31K
1.31%-32.61K
-17.48%-39.01K
-182.26%-15.91K
---8.08K
83.61%-33.04K
-51.93%-33.21K
74.10%-5.64K
----
Other net revenue
152.58%8M
185.33%4.56M
-54.75%6.99M
-53.88%4.48M
-58.19%3.17M
-52.89%1.6M
-10.35%15.45M
5.77%9.72M
33.28%7.57M
4.16%3.39M
Fair value change income
-115.89%-65.02K
131.55%234.42K
115.58%125.72K
77.89%-145.88K
384.15%409.09K
-45.94%101.24K
-182.39%-807.09K
-210.80%-659.83K
-124.37%-143.97K
855.61%187.26K
Invest income
24.47%2.02M
0.11%850.06K
-59.46%3.56M
-58.76%2.92M
-66.78%1.62M
-61.05%849.09K
44.21%8.79M
83.54%7.08M
120.02%4.89M
52.15%2.18M
Asset deal income
----
----
----
----
----
----
1,560.57%166.51K
-11,027.02%-933.8K
----
----
Other revenue
416.63%6.05M
400.08%3.48M
-54.08%3.37M
-57.98%1.8M
-59.31%1.17M
-32.78%695.66K
-28.89%7.34M
-8.78%4.28M
1.48%2.88M
-44.13%1.03M
Operating profit
173.72%38.59M
109.53%18.73M
16.74%48.27M
-10.75%30.39M
-41.81%14.1M
6.31%8.94M
-5.41%41.35M
-1.41%34.05M
-1.26%24.22M
-31.89%8.41M
Add:Non operating Income
34.02%10.81K
56.23%10.75K
581.43%267.76K
-67.85%12.07K
-37.72%8.07K
2,099.17%6.88K
-99.51%39.29K
-98.75%37.53K
568.96%12.95K
76.71%312.76
Less:Non operating expense
-30.96%152.93K
36.44%13.17K
-63.95%513.36K
210.91%550.4K
197.53%221.5K
-81.66%9.65K
1,010.24%1.42M
89.47%177.03K
10.57%74.45K
76.32%52.63K
Total profit
176.91%38.44M
109.57%18.72M
20.17%48.02M
-11.97%29.85M
-42.54%13.88M
6.94%8.93M
-22.55%39.96M
-9.44%33.91M
-1.25%24.16M
-32.15%8.35M
Less:Income tax cost
203.91%6.05M
238.05%3.78M
68.99%7.14M
9.81%4.43M
-35.64%1.99M
-7.24%1.12M
-38.89%4.23M
-25.53%4.03M
-13.03%3.09M
-37.38%1.2M
Net profit
172.38%32.39M
91.19%14.94M
14.39%40.88M
-14.90%25.42M
-43.56%11.89M
9.33%7.82M
-20.02%35.73M
-6.72%29.88M
0.76%21.07M
-31.18%7.15M
Net profit from continuing operation
172.38%32.39M
91.19%14.94M
14.39%40.88M
-14.90%25.42M
-43.56%11.89M
9.33%7.82M
-20.02%35.73M
-6.72%29.88M
0.76%21.07M
-31.18%7.15M
Less:Minority Profit
----
----
----
----
----
----
-382.05%-156.87K
-819.74%-156.87K
-1,129.04%-157.48K
-29.09%-9.48K
Net profit of parent company owners
172.38%32.39M
91.19%14.94M
13.89%40.88M
-15.35%25.42M
-43.98%11.89M
9.19%7.82M
-19.73%35.89M
-6.28%30.03M
1.45%21.23M
-31.14%7.16M
Earning per share
Basic earning per share
172.22%0.49
91.67%0.23
14.81%0.62
-15.56%0.38
-43.75%0.18
9.09%0.12
-31.65%0.54
-25.00%0.45
-23.81%0.32
-47.62%0.11
Diluted earning per share
172.22%0.49
91.67%0.23
14.81%0.62
-15.56%0.38
-43.75%0.18
9.09%0.12
-31.65%0.54
-25.00%0.45
-23.81%0.32
-47.62%0.11
Other composite income
400.78
-86.87%136.48K
1.04M
Other composite income of parent company owners
--400.78
----
-86.87%136.48K
----
----
----
--1.04M
----
----
----
Total composite income
172.39%32.39M
91.19%14.94M
11.53%41.01M
-14.90%25.42M
-43.56%11.89M
9.33%7.82M
-17.70%36.77M
-6.72%29.88M
0.76%21.07M
-31.18%7.15M
Total composite income of parent company owners
172.39%32.39M
91.19%14.94M
11.06%41.01M
-15.35%25.42M
-43.98%11.89M
9.19%7.82M
-17.41%36.93M
-6.28%30.03M
1.45%21.23M
-31.14%7.16M
Total composite income of minority owners
----
----
----
----
----
----
-382.05%-156.87K
-819.74%-156.87K
-1,129.04%-157.48K
-29.09%-9.48K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Huaxing Certified Public Accountants (Special General Partnership)
--
--
--
Huaxing Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue 42.39%122.05M28.59%57.21M18.24%230.87M4.69%145.78M-9.80%85.72M19.35%44.49M26.96%195.25M34.75%139.25M38.24%95.02M14.63%37.27M
Operating revenue 42.39%122.05M28.59%57.21M18.24%230.87M4.69%145.78M-9.80%85.72M19.35%44.49M26.96%195.25M34.75%139.25M38.24%95.02M14.63%37.27M
Other operating revenue 131.88%2.88M----1,308.63%3.33M------1.24M------236.57K------0----
Total operating cost 22.30%91.46M15.86%43.04M11.95%189.59M4.31%119.87M-4.58%74.79M15.16%37.15M33.03%169.36M47.35%114.92M57.11%78.37M37.69%32.25M
Operating cost 49.26%25.81M23.73%10.7M33.03%41.54M34.92%27.67M24.75%17.29M44.03%8.65M15.28%31.23M9.75%20.51M8.14%13.86M-4.86%6.01M
Operating tax surcharges 14.79%2.27M19.42%1.16M123.75%4.57M145.54%3.05M220.05%1.98M1,237.64%967.22K211.09%2.04M119.97%1.24M69.31%617.91K-52.42%72.31K
Operating expense -3.32%22.77M1.91%12.23M-12.13%61.75M-22.37%38.39M-33.38%23.55M-8.23%12.01M44.61%70.27M69.24%49.45M86.65%35.35M55.58%13.08M
Administration expense 49.29%29.71M43.57%13.51M54.18%54.42M42.36%32.95M32.04%19.9M29.47%9.41M44.61%35.3M54.47%23.15M62.46%15.07M54.63%7.27M
Financial expense -398.55%-144.51K-65.10%158.09K630.85%531.59K142.81%253.17K191.19%48.41K117.78%453.01K-114.67%-100.14K-226.76%-591.31K-111.37%-53.08K-22.93%208.01K
-Interest expense (Financial expense) -22.92%866.9K-11.70%508.27K23.80%2.21M157.60%1.67M441.83%1.12M436.00%575.62K260.58%1.78M54.35%649.97K-19.14%207.57K-15.60%107.39K
-Interest Income (Financial expense) -2.58%-976.78K5.21%-469.69K-90.35%-1.88M-177.23%-1.41M-610.99%-952.21K-838.50%-495.53K-151.02%-989.7K-90.69%-509.01K-54.86%-133.93K-47.45%-52.8K
Research and development -8.05%11.05M-6.77%5.28M-12.53%26.78M-17.03%17.56M-11.16%12.02M0.74%5.66M18.31%30.61M50.41%21.16M68.64%13.53M56.80%5.62M
Credit Impairment Loss 52.14%-10.94K77.60%-9.26K-330.09%-36.56K-210.77%-51.1K52.28%-22.87K-210.69%-41.35K-132.18%-8.5K-129.49%-16.44K-190.48%-47.91K-237.27%-13.31K
Asset Impairment Loss 98.67%-212.18116.18%1.31K1.31%-32.61K-17.48%-39.01K-182.26%-15.91K---8.08K83.61%-33.04K-51.93%-33.21K74.10%-5.64K----
Other net revenue 152.58%8M185.33%4.56M-54.75%6.99M-53.88%4.48M-58.19%3.17M-52.89%1.6M-10.35%15.45M5.77%9.72M33.28%7.57M4.16%3.39M
Fair value change income -115.89%-65.02K131.55%234.42K115.58%125.72K77.89%-145.88K384.15%409.09K-45.94%101.24K-182.39%-807.09K-210.80%-659.83K-124.37%-143.97K855.61%187.26K
Invest income 24.47%2.02M0.11%850.06K-59.46%3.56M-58.76%2.92M-66.78%1.62M-61.05%849.09K44.21%8.79M83.54%7.08M120.02%4.89M52.15%2.18M
Asset deal income ------------------------1,560.57%166.51K-11,027.02%-933.8K--------
Other revenue 416.63%6.05M400.08%3.48M-54.08%3.37M-57.98%1.8M-59.31%1.17M-32.78%695.66K-28.89%7.34M-8.78%4.28M1.48%2.88M-44.13%1.03M
Operating profit 173.72%38.59M109.53%18.73M16.74%48.27M-10.75%30.39M-41.81%14.1M6.31%8.94M-5.41%41.35M-1.41%34.05M-1.26%24.22M-31.89%8.41M
Add:Non operating Income 34.02%10.81K56.23%10.75K581.43%267.76K-67.85%12.07K-37.72%8.07K2,099.17%6.88K-99.51%39.29K-98.75%37.53K568.96%12.95K76.71%312.76
Less:Non operating expense -30.96%152.93K36.44%13.17K-63.95%513.36K210.91%550.4K197.53%221.5K-81.66%9.65K1,010.24%1.42M89.47%177.03K10.57%74.45K76.32%52.63K
Total profit 176.91%38.44M109.57%18.72M20.17%48.02M-11.97%29.85M-42.54%13.88M6.94%8.93M-22.55%39.96M-9.44%33.91M-1.25%24.16M-32.15%8.35M
Less:Income tax cost 203.91%6.05M238.05%3.78M68.99%7.14M9.81%4.43M-35.64%1.99M-7.24%1.12M-38.89%4.23M-25.53%4.03M-13.03%3.09M-37.38%1.2M
Net profit 172.38%32.39M91.19%14.94M14.39%40.88M-14.90%25.42M-43.56%11.89M9.33%7.82M-20.02%35.73M-6.72%29.88M0.76%21.07M-31.18%7.15M
Net profit from continuing operation 172.38%32.39M91.19%14.94M14.39%40.88M-14.90%25.42M-43.56%11.89M9.33%7.82M-20.02%35.73M-6.72%29.88M0.76%21.07M-31.18%7.15M
Less:Minority Profit -------------------------382.05%-156.87K-819.74%-156.87K-1,129.04%-157.48K-29.09%-9.48K
Net profit of parent company owners 172.38%32.39M91.19%14.94M13.89%40.88M-15.35%25.42M-43.98%11.89M9.19%7.82M-19.73%35.89M-6.28%30.03M1.45%21.23M-31.14%7.16M
Earning per share
Basic earning per share 172.22%0.4991.67%0.2314.81%0.62-15.56%0.38-43.75%0.189.09%0.12-31.65%0.54-25.00%0.45-23.81%0.32-47.62%0.11
Diluted earning per share 172.22%0.4991.67%0.2314.81%0.62-15.56%0.38-43.75%0.189.09%0.12-31.65%0.54-25.00%0.45-23.81%0.32-47.62%0.11
Other composite income 400.78-86.87%136.48K1.04M
Other composite income of parent company owners --400.78-----86.87%136.48K--------------1.04M------------
Total composite income 172.39%32.39M91.19%14.94M11.53%41.01M-14.90%25.42M-43.56%11.89M9.33%7.82M-17.70%36.77M-6.72%29.88M0.76%21.07M-31.18%7.15M
Total composite income of parent company owners 172.39%32.39M91.19%14.94M11.06%41.01M-15.35%25.42M-43.98%11.89M9.19%7.82M-17.41%36.93M-6.28%30.03M1.45%21.23M-31.14%7.16M
Total composite income of minority owners -------------------------382.05%-156.87K-819.74%-156.87K-1,129.04%-157.48K-29.09%-9.48K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Huaxing Certified Public Accountants (Special General Partnership)------Huaxing Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data